Most antibody sequence data that’s publicly available comes from heavy chains, since they’re cheaper and easier to sequence than paired heavy–light chains. However, studying the 3D structure of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback